Latest News

Date Title Topic
09 May 2014 IMPAKT 2014 News: Combination of mTOR and AKT Inhibitors in Patients with Advanced Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
09 May 2014 IMPAKT 2014 News: Molecular Subtype of a Breast Cancer Relapse Influences Patient Post-Relapse Survival Breast cancer - Pathology/Molecular biology - Translational research
09 May 2014 IMPAKT 2014 News: Adoption of Multi-gene Assays in Hormone Receptor-Positive, HER2-Negative Breast Cancer Breast cancer - Personalised medicine
09 May 2014 IMPAKT 2014 News: Therapeutic Effect and Markers of Response of Palbociclib in HER2-Positive Breast Cancer Models Breast cancer - Translational research - Anticancer agents & Biologic therapy
09 May 2014 IMPAKT 2014 News: Enzalutamide With or Without an Aromatase Inhibitor for Advanced Breast Cancer Breast cancer - Translational research
07 May 2014 Molecular Tumour Board Helps in Advanced Cancer Cases Personalised medicine
06 May 2014 European Medicines Agency Recommends a Variation to the Terms of the Marketing Authorisation for Denosumab Genitourinary cancers - Palliative and supportive care
05 May 2014 Withdrawal of Application for EMA Change to the Marketing Authorisation of Pazopanib Gynaecologic malignancies - Anticancer agents & Biologic therapy
02 May 2014 European Medicines Agency Recommends a Variation to the Terms of the Marketing Authorisation for Two HPV Vaccines Cancer prevention - Gynaecologic malignancies - Gastrointestinal cancers
07 Jul 2014 Updated 2014 ESMO Clinical Practice Guidelines
30 Apr 2014 The Role of Postoperative Radiation Therapy for Endometrial Cancer Gynaecologic malignancies
29 Apr 2014 EMA Recommends Granting a Marketing Authorisation for Trametinib and Extending Indications for Sorafenib Melanoma - Endocrine cancers - Anticancer agents & Biologic therapy
28 Apr 2014 EORTC and SIOG Update Expert Opinion on Management of Elderly Patients with NSCLC Cancer in Special Situations - Lung and other thoracic tumours
Curriculum in Translational Research in Breast Cancer
25 Apr 2014 Recommendations for a Molecular Diagnostics Curriculum Personalised medicine - Bioethics, legal and economic issues - Translational research